Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Tools & Technology › Sequencing › DNAe Receives $10.9M From BARDA for Near-Patient NGS Prototype

DNAe Receives $10.9M From BARDA for Near-Patient NGS Prototype

Nov 02, 2018
|
staff reporter

NEW YORK (GenomeWeb) – DNA Electronics said today that the Biomedical Advanced Research and Development Authority has approved the second phase of a contract for the development of a next-generation sequencing platform for rapid diagnosis of antimicrobial resistant infections and influenza.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Infectious Disease

  1. Quest, Walmart Teaming Up to Deliver SARS-CoV-2 Home Sampling Kits Via Drone

  2. Loop Diagnostics Developing Lateral Flow Test Platform for Sepsis

    Premium

  3. Ortho Clinical Diagnostics Nabs $12.9M BARDA Award for SARS-CoV-2 Antigen, Antibody Tests

  4. Becton Dickinson Submits Premarket Approval Supplement to FDA for HPV Assay

  5. FDA Grants Emergency Use Authorization for GK Pharmaceuticals Coronavirus Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.